{"database":"MassIVE","file_versions":[{"headers":{"Content-Type":["application/json"]},"body":{"files":{"Other":["ftp://massive-ftp.ucsd.edu/v07/MSV000094271/"]},"type":"primary"},"statusCodeValue":200,"statusCode":"OK"}],"scores":null,"additional":{"submitter":["Petra Janning"],"full_dataset_link":["https://massive.ucsd.edu/ProteoSAFe/dataset.jsp?task=e571a349d8e54e16ad5a9438e7a92e60"],"submitter_email":["petra.janning@mpi-dortmund.mpg.de"],"sample_protocol":[""],"repository":["MassIVE"],"file_size":["11"],"ptm_modification":["UNIMOD:121 - \"Ubiquitinylation residue.\""],"data_protocol":[""],"omics_type":["Proteomics"],"instrument_platform":["Q Exactive Plus"],"species":["Homo Sapiens (ncbitaxon:9606)"],"submitter_affiliation":["MPI of Molecular Physiology"],"description_synonyms":["indo, BxPC3 cell, Controlling, preventive therapy, MS2., reference sample, MS/MS, prophylaxis, INDO, Ido, IDO, Bx-PC3 cell, IDO-1, Cell, prevention, preventive measures, lysate, control, Indo, BxPC3, ido, BxPC-3 cell, prevention and control, tandem MS, Controlled"],"name_synonyms":["indo, Indo, INDO, Cell., assay, ido, Ido, IDO, determination, IDO-1, chemical analysis"],"additional_accession":["PXD050475"]},"is_claimable":false,"name":"Analysis of ubiquitinylation sites of IDO1 after incubation of cells with iDeg-1","description":"IFNgamma-stimulated BxPC3 cells were treated with 20 uM iDeg-1 or DMSO as a control for 6 h prior to lysate preparation. IDO1 was immunoprecipitated and the enriched fraction was digested and analyzed by nanoLC-MS/MS.","dates":{"publication":"Fri Mar 08 01:26:00 GMT 2024"},"accession":"MSV000094271","cross_references":{}}